Insiders Hansa Biopharma AB

Equities

HNSA

SE0002148817

Market Closed - Nasdaq Stockholm Other stock markets 08:59:58 10/05/2024 pm IST			5-day change	1st Jan Change
31.94 ^SEK	+4.31%		+7.40%	+21.91%

18/04	Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
18/04	Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansa Biopharma Hires New CFO	22/02	MT
Hansa Biopharma Nomination Committee Formed	13/12	CI
Sweden's Hansa Biopharma CFO to Depart in February 2024	27/11	MT
Hahansa Biopharma AB Announces Resignation of Donato Spota as Chief Financial Officer, Effective 28 February 2024	27/11	CI
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer	01/23/01	MT
Hitto Kaufmann Appointed Chief Scientific Officer of Hansa Biopharma, Effective 1 December 2023	01/23/01	CI
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	06/23/06	AQ
Hansa Biopharma Names Former Pfizer Exec as Chief Commercial Officer	03/23/03	MT
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	03/23/03	AQ
Hansa Biopharma AB Appoints Matthew Shaulis as Chief Commercial Officer and US President of Hansa Biopharma	03/23/03	CI
Hansa Biopharma Chief Scientific Officer to Step Down in 2024	30/23/30	MT
Hansa Biopharma Announces Planned Departure of Chief Scientific Officer Christian Kjellman	30/23/30	CI
Correction Hansa Biopharma Nomination Committee formed	29/22/29	AQ
Correction: Hansa Biopharma Nomination Committee formed	28/22/28	AQ
Hansa Biopharma Nomination Committee formed - December 23, 2022	23/22/23	AQ
Hansa Biopharma Nomination Committee formed	23/22/23	AQ
Hansa Biopharma AB Announces Formation of Nomination Committee	23/22/23	CI
Hansa Biopharma AB Appoints Peter Nicklin as A New Member of the Board of Director	30/22/30	CI
Hansa Biopharma AB's Current Chair Ulf Wiinberg Has Chosen to Not Stand for Re-Election	30/22/30	CI
Hansa Biopharma AB Announces Ulf Wiinberg Not to Stand for Re-Election as Director	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Hansa Biopharma AB

Equities

HNSA

SE0002148817

Insiders

Filters